Hoth Therapeutics Stock Market Value
| HOTH Stock | USD 1.50 0.08 5.06% |
| Symbol | Hoth |
Hoth Therapeutics Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Hoth Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hoth Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hoth Therapeutics.
| 01/26/2024 |
| 01/20/2025 |
If you would invest 0.00 in Hoth Therapeutics on January 26, 2024 and sell it all today you would earn a total of 0.00 from holding Hoth Therapeutics or generate 0.0% return on investment in Hoth Therapeutics over 360 days. Hoth Therapeutics is related to or competes with Avenue Therapeutics, Revelation Biosciences, Virax Biolabs, Zura Bio, Phio Pharmaceuticals, Sonnet Biotherapeutics, and 180 Life. Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical n... More
Hoth Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hoth Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hoth Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.6 | |||
| Information Ratio | 0.0955 | |||
| Maximum Drawdown | 196.04 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 5.19 |
Hoth Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hoth Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hoth Therapeutics' standard deviation. In reality, there are many statistical measures that can use Hoth Therapeutics historical prices to predict the future Hoth Therapeutics' volatility.| Risk Adjusted Performance | 0.0905 | |||
| Jensen Alpha | 2.19 | |||
| Total Risk Alpha | 1.63 | |||
| Sortino Ratio | 0.3831 | |||
| Treynor Ratio | (1.37) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hoth Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hoth Therapeutics Backtested Returns
Hoth Therapeutics is out of control given 3 months investment horizon. Hoth Therapeutics holds Efficiency (Sharpe) Ratio of 0.0962, which attests that the entity had a 0.0962 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.22% are justified by taking the suggested risk. Use Hoth Therapeutics Downside Deviation of 5.6, risk adjusted performance of 0.0905, and Market Risk Adjusted Performance of (1.36) to evaluate company specific risk that cannot be diversified away. Hoth Therapeutics holds a performance score of 7 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -1.58, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Hoth Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Hoth Therapeutics is expected to outperform it. Use Hoth Therapeutics potential upside, as well as the relationship between the kurtosis and day typical price , to analyze future returns on Hoth Therapeutics.
Auto-correlation | -0.36 |
Poor reverse predictability
Hoth Therapeutics has poor reverse predictability. Overlapping area represents the amount of predictability between Hoth Therapeutics time series from 26th of January 2024 to 24th of July 2024 and 24th of July 2024 to 20th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hoth Therapeutics price movement. The serial correlation of -0.36 indicates that just about 36.0% of current Hoth Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.36 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Hoth Therapeutics lagged returns against current returns
Autocorrelation, which is Hoth Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hoth Therapeutics' stock expected returns. We can calculate the autocorrelation of Hoth Therapeutics returns to help us make a trade decision. For example, suppose you find that Hoth Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Hoth Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hoth Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hoth Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hoth Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Hoth Therapeutics Lagged Returns
When evaluating Hoth Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hoth Therapeutics stock have on its future price. Hoth Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hoth Therapeutics autocorrelation shows the relationship between Hoth Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Hoth Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:Check out Hoth Therapeutics Correlation, Hoth Therapeutics Volatility and Hoth Therapeutics Alpha and Beta module to complement your research on Hoth Therapeutics. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Hoth Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.